Status:
COMPLETED
Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients
Lead Sponsor:
Seoul National University Hospital
Conditions:
Breast Cancer
Vaginal Atrophy
Eligibility:
FEMALE
20+ years
Phase:
PHASE3
Brief Summary
1. Although after treatment for breast cancer such as chemotherapy or hormonal therapy, urogenital atrophy is common, the patients are seldomly treated for several reasons. Management of this problem ...
Eligibility Criteria
Inclusion
- breast cancer patients
- who are treated with chemotherapy or hormonal therapy
- who experience no menstruation after the previous therapy
- who complain of vaginal dryness
Exclusion
- other cancer patients
- other severe disease
- poor compliance
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00607295
Start Date
December 1 2007
End Date
February 1 2009
Last Update
July 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744